Literature DB >> 3747804

Co-activation of sprinter and distance runner muscles in isokinetic exercise.

L R Osternig, J Hamill, J E Lander, R Robertson.   

Abstract

The purpose of this study was to investigate the extent of co-activation of quadriceps and hamstring musculature in sprinters and distance runners. Nine female intercollegiate track athletes performed maximal knee extensions and flexions on a modified orthotron isokinetic dynamometer at two speeds (100 degrees and 400 degrees X s-1). Simultaneous recordings of torque, joint position, and agonist/antagonist electromyographic activity from the quadriceps and hamstrings were computer-processed. The results revealed the hamstrings to be considerably more active during knee extension than the quadriceps during flexion. The integrated electromyographic activity of co-contracting hamstrings and quadriceps, throughout the joint range, averaged 33 and 6%, respectively, of the same muscle group during its agonist phase. Hamstring co-activation increased sharply during the last 25% of knee extension, generating 58% of the integrated electromyographic agonist activity. Co-activation of the sprinters' hamstrings was four times that of distance runners (57/14%), however, the faster speed of movement (400 degrees X s-1) increased hamstring coactivation of distance runners more acutely than sprinters in the final phase of extension. The data suggest that the hamstrings are used to a much greater extent than quadriceps for limb deceleration and that the distraction of antagonist muscle tension should be considered when analyzing agonist isokinetic torques. Furthermore, the relatively high co-activation of the hamstrings, particularly during the last 25% of extension, may induce hamstring soreness or strain in vulnerable subjects.

Mesh:

Year:  1986        PMID: 3747804

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  19 in total

Review 1.  Neural influences on sprint running: training adaptations and acute responses.

Authors:  A Ross; M Leveritt; S Riek
Journal:  Sports Med       Date:  2001       Impact factor: 11.136

2.  The force-velocity relationship of the human soleus muscle during submaximal voluntary lengthening actions.

Authors:  G J Pinniger; J R Steele; A G Cresswell
Journal:  Eur J Appl Physiol       Date:  2003-07-09       Impact factor: 3.078

Review 3.  Knee extensor performance in runners. Differences between specific athletes and implications for injury prevention.

Authors:  C Johansson
Journal:  Sports Med       Date:  1992-08       Impact factor: 11.136

4.  Initial conditions influence the characteristics of ballistic contractions in the ankle dorsiflexors.

Authors:  Chris Richartz; Morgan Lévénez; Julien Boucart; Jacques Duchateau
Journal:  Eur J Appl Physiol       Date:  2010-07-06       Impact factor: 3.078

5.  Functional torque-velocity and power-velocity characteristics of elite athletes.

Authors:  N A Taylor; J D Cotter; S N Stanley; R N Marshall
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1991

Review 6.  The effects of strength training and disuse on the mechanisms of fatigue.

Authors:  D G Behm; D M St-Pierre
Journal:  Sports Med       Date:  1998-03       Impact factor: 11.136

Review 7.  Developments in the use of the hamstring/quadriceps ratio for the assessment of muscle balance.

Authors:  Rosalind Coombs; Gerard Garbutt
Journal:  J Sports Sci Med       Date:  2002-09-01       Impact factor: 2.988

8.  Anatomical and neuromuscular variables strongly predict maximum knee extension torque in healthy men.

Authors:  J Trezise; N Collier; A J Blazevich
Journal:  Eur J Appl Physiol       Date:  2016-04-13       Impact factor: 3.078

Review 9.  The adaptations to strength training : morphological and neurological contributions to increased strength.

Authors:  Jonathan P Folland; Alun G Williams
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

Review 10.  Velocity specificity of resistance training.

Authors:  D G Behm; D G Sale
Journal:  Sports Med       Date:  1993-06       Impact factor: 11.136

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.